Dorna Therapeutics, Inc. — Form D
Dorna Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-31. The offering totals $300K, of which $300K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-07-31
- Form: D
- Accession: 0001748360-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $300K
- Investors: 5
- Date of first sale: 2018-07-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-318201
Issuer
- Name: Dorna Therapeutics, Inc.
- CIK: 0001748360
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 294 FOREST STREET, WALTHAM, MA, 02452
- Phone: 617-906-2696
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Mousa Jafari | Director | Waltham, MA |
| John J Quinn | Director | Indianapolis, IN |
| John Alfons Tabaczynski | Director | Groton, MA |
| Mousa Jafari | Executive Officer | Waltham, MA |
| Mousa Jafari | Promoter | Waltham, MA |
| John Alfons Tabaczynski | Promoter | Groton, MA |
More